# Randomization of Botox for Stent Pain and Irritative Voiding Symptoms

> **NCT02078895** · PHASE3 · TERMINATED · sponsor: **University of California, Irvine** · enrollment: 15 (actual)

## Conditions studied

- Lower Urinary Tract Discomfort
- Stent Pain

## Interventions

- **DRUG:** Botox

## Key facts

- **NCT ID:** NCT02078895
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** The study was terminated due to low enrollment
- **Last updated:** 2018-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02078895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02078895, "Randomization of Botox for Stent Pain and Irritative Voiding Symptoms". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02078895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*